ArticleNeuropsychiatric disease and treatment2022

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials.

Mingjun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.